Literature DB >> 27461364

Galectin-3, Cardiac Function, and Fibrosis.

Wouter C Meijers1, Natalia López-Andrés2, Rudolf A de Boer3.   

Abstract

This Correspondence relates to the article by Frunza et al (Myocardial Galectin-3 Expression Is Associated with Remodeling of the Pressure-Overloaded Heart and May Delay the Hypertrophic Response without Affecting Survival, Dysfunction, and Cardiac Fibrosis. Am J Pathol 2016, 186:1114-1127).
Copyright © 2016 American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27461364     DOI： 10.1016/j.ajpath.2016.05.002

Source DB:  PubMed          Journal:  Am J Pathol        ISSN： 0002-9440            Impact factor:   4.307


  7 in total

1.  Cystatin C and galectin-3 as therapeutic targets in heart failure.

Authors:  Christos Zivlas; Filippos Triposkiadis; Stelios Psarras; Gregory Giamouzis; Ioannis Skoularigis; Stavros Chryssanthopoulos; Alkistis Kapelouzou; Steve Ramcharitar; Edward Barnes; Evangelos Papasteriadis; Dennis Cokkinos
Journal:  Ther Adv Cardiovasc Dis       Date:  2018-05-31

2.  Moving galectin-3 closer to the goal line.

Authors:  Jonathan A Kirk; Rudolf A de Boer
Journal:  Am J Physiol Heart Circ Physiol       Date:  2018-12-21       Impact factor: 4.733

Review 3.  Intermediate filaments in cardiomyopathy.

Authors:  Mary Tsikitis; Zoi Galata; Manolis Mavroidis; Stelios Psarras; Yassemi Capetanaki
Journal:  Biophys Rev       Date:  2018-07-19

4.  Trypanosoma cruzi cleaves galectin-3 N-terminal domain to suppress its innate microbicidal activity.

Authors:  M Pineda; L Corvo; F Callejas-Hernández; M Fresno; P Bonay
Journal:  Clin Exp Immunol       Date:  2019-10-27       Impact factor: 4.330

Review 5.  Circulating heart failure biomarkers beyond natriuretic peptides: review from the Biomarker Study Group of the Heart Failure Association (HFA), European Society of Cardiology (ESC).

Authors:  Wouter C Meijers; Antoni Bayes-Genis; Alexandre Mebazaa; Johann Bauersachs; John G F Cleland; Andrew J S Coats; James L Januzzi; Alan S Maisel; Kenneth McDonald; Thomas Mueller; A Mark Richards; Petar Seferovic; Christian Mueller; Rudolf A de Boer
Journal:  Eur J Heart Fail       Date:  2021-10-10       Impact factor: 17.349

Review 6.  Galectin-3 as a novel biomarker for disease diagnosis and a target for therapy (Review).

Authors:  Rui Dong; Min Zhang; Qunying Hu; Shan Zheng; Andrew Soh; Yijie Zheng; Hui Yuan
Journal:  Int J Mol Med       Date:  2017-12-05       Impact factor: 4.101

7.  Stimulation of β-adrenoceptors up-regulates cardiac expression of galectin-3 and BIM through the Hippo signalling pathway.

Authors:  Wei-Bo Zhao; Qun Lu; My-Nhan Nguyen; Yidan Su; Mark Ziemann; Li-Na Wang; Helen Kiriazis; Hamsa Puthalakath; Junichi Sadoshima; Hou-Yuan Hu; Xiao-Jun Du
Journal:  Br J Pharmacol       Date:  2019-05-30       Impact factor: 8.739
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.